JP2022522819A5 - - Google Patents
Info
- Publication number
- JP2022522819A5 JP2022522819A5 JP2021551939A JP2021551939A JP2022522819A5 JP 2022522819 A5 JP2022522819 A5 JP 2022522819A5 JP 2021551939 A JP2021551939 A JP 2021551939A JP 2021551939 A JP2021551939 A JP 2021551939A JP 2022522819 A5 JP2022522819 A5 JP 2022522819A5
- Authority
- JP
- Japan
- Prior art keywords
- approximately
- pharmaceutical composition
- composition according
- leucine
- acetyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024155453A JP2024170602A (ja) | 2019-03-02 | 2024-09-10 | 疾患の治療のためのロイシン、アセチルロイシン、及び関連類似体 |
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962812987P | 2019-03-02 | 2019-03-02 | |
| US62/812,987 | 2019-03-02 | ||
| US201962842296P | 2019-05-02 | 2019-05-02 | |
| US62/842,296 | 2019-05-02 | ||
| US201962888894P | 2019-08-19 | 2019-08-19 | |
| US62/888,894 | 2019-08-19 | ||
| US201962895144P | 2019-09-03 | 2019-09-03 | |
| US62/895,144 | 2019-09-03 | ||
| PCT/IB2020/051767 WO2020178721A1 (en) | 2019-03-02 | 2020-03-02 | Leucine, acetyl leucine, and related analogs for treating disease |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024155453A Division JP2024170602A (ja) | 2019-03-02 | 2024-09-10 | 疾患の治療のためのロイシン、アセチルロイシン、及び関連類似体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022522819A JP2022522819A (ja) | 2022-04-20 |
| JP2022522819A5 true JP2022522819A5 (https=) | 2023-03-13 |
| JP7555346B2 JP7555346B2 (ja) | 2024-09-24 |
Family
ID=69845470
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021551939A Active JP7555346B2 (ja) | 2019-03-02 | 2020-03-02 | 疾患の治療のためのロイシン、アセチルロイシン、及び関連類似体 |
| JP2024155453A Pending JP2024170602A (ja) | 2019-03-02 | 2024-09-10 | 疾患の治療のためのロイシン、アセチルロイシン、及び関連類似体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024155453A Pending JP2024170602A (ja) | 2019-03-02 | 2024-09-10 | 疾患の治療のためのロイシン、アセチルロイシン、及び関連類似体 |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US20220142959A1 (https=) |
| EP (2) | EP4464378A3 (https=) |
| JP (2) | JP7555346B2 (https=) |
| KR (2) | KR102941068B1 (https=) |
| CN (2) | CN119097618A (https=) |
| AU (2) | AU2020231189B2 (https=) |
| BR (1) | BR112021017203A2 (https=) |
| CA (1) | CA3131948A1 (https=) |
| DK (1) | DK3934637T3 (https=) |
| ES (1) | ES2990183T3 (https=) |
| FI (1) | FI3934637T3 (https=) |
| HR (1) | HRP20241150T1 (https=) |
| HU (1) | HUE068527T2 (https=) |
| IL (2) | IL321899A (https=) |
| LT (1) | LT3934637T (https=) |
| MA (1) | MA55199B1 (https=) |
| MD (1) | MD3934637T2 (https=) |
| MX (2) | MX2021010568A (https=) |
| PL (1) | PL3934637T3 (https=) |
| PT (1) | PT3934637T (https=) |
| RS (1) | RS65849B1 (https=) |
| SG (1) | SG11202109512SA (https=) |
| SI (1) | SI3934637T1 (https=) |
| SM (1) | SMT202400334T1 (https=) |
| WO (1) | WO2020178721A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201709459D0 (en) | 2017-06-14 | 2017-07-26 | Intrabio Ltd | Treatment for migraine |
| EP3886986A1 (en) * | 2018-12-06 | 2021-10-06 | IntraBio Ltd | Deuterated analogs of acetyl-leucine |
| US20250025442A1 (en) * | 2020-12-10 | 2025-01-23 | Texas Tech University System | BCAA-Lowering Compounds for Prevention and/or Treatment of Alzheimer's Disease and Related Disorders |
| WO2022264037A1 (en) * | 2021-06-14 | 2022-12-22 | Intrabio Ltd. | Branched-chain amino acid derivatives to treat disease |
| WO2024243004A2 (en) * | 2023-05-19 | 2024-11-28 | The Children's Hospital Of Philadelphia | Compositions and methods for treating traumatic brain injury |
| US12403111B2 (en) | 2024-02-02 | 2025-09-02 | SynGAP Research Fund | Compositions and methods for treating neurodevelopmental disorders |
| WO2025175092A1 (en) * | 2024-02-14 | 2025-08-21 | Intrabio Inc. | Acetyl leucine for treating syngap1-related disorders |
| WO2025264957A2 (en) * | 2024-06-20 | 2025-12-26 | Intrabio Inc. | Acetyl leucine for treating neurodevelopmental disorders |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060063827A1 (en) * | 2004-09-23 | 2006-03-23 | Yu Ruey J | Systemic administration of therapeutic amino acids and N-acetylamino acids |
| FR2905600B1 (fr) * | 2006-09-13 | 2010-01-15 | Pf Medicament | Traitement des vertiges par l'acetyl-l-leucine. |
| TN2010000251A1 (fr) * | 2010-06-03 | 2011-11-11 | Rekik Raouf | N-acetyl-dl-leucine medicament neuro et retino protecteur |
| LT2588130T (lt) | 2010-06-25 | 2016-12-12 | Shire Human Genetic Therapies, Inc. | Terapinės priemonės pristatymas cns |
| US20140080885A1 (en) * | 2012-09-13 | 2014-03-20 | University Of South Florida (A Florida Non-Profit Corporation) | Methods of treating traumatic brain injury |
| ES2994242T3 (en) * | 2016-04-19 | 2025-02-05 | Intrabio Ltd | Acetyl-leucine or a pharmaceutically acceptable salt thereof for improved mobility |
| TN2016000259A1 (en) * | 2016-06-27 | 2017-10-06 | Rekik Raouf | Salbutamol (albuterol) eye protective medicament. |
| WO2018029658A1 (en) | 2016-08-11 | 2018-02-15 | Intrabio Limited | Therapeutic agents for neurodegenerative diseases |
| DK3359146T3 (en) | 2016-08-11 | 2019-04-08 | Intrabio Ltd | PHARMACEUTICAL COMPOSITIONS AND USES AGAINST LYSOSOMAL STORAGE DISEASES |
| JP7370960B2 (ja) * | 2017-08-14 | 2023-10-30 | アクセラ・ヘルス・インコーポレイテッド | 神経細胞損傷の治療のためのアミノ酸組成物 |
-
2020
- 2020-03-02 SM SM20240334T patent/SMT202400334T1/it unknown
- 2020-03-02 MX MX2021010568A patent/MX2021010568A/es unknown
- 2020-03-02 PT PT207120296T patent/PT3934637T/pt unknown
- 2020-03-02 ES ES20712029T patent/ES2990183T3/es active Active
- 2020-03-02 MD MDE20220032T patent/MD3934637T2/ro unknown
- 2020-03-02 IL IL321899A patent/IL321899A/en unknown
- 2020-03-02 SI SI202030476T patent/SI3934637T1/sl unknown
- 2020-03-02 CA CA3131948A patent/CA3131948A1/en active Pending
- 2020-03-02 BR BR112021017203A patent/BR112021017203A2/pt unknown
- 2020-03-02 PL PL20712029.6T patent/PL3934637T3/pl unknown
- 2020-03-02 AU AU2020231189A patent/AU2020231189B2/en active Active
- 2020-03-02 WO PCT/IB2020/051767 patent/WO2020178721A1/en not_active Ceased
- 2020-03-02 FI FIEP20712029.6T patent/FI3934637T3/fi active
- 2020-03-02 RS RS20240913A patent/RS65849B1/sr unknown
- 2020-03-02 SG SG11202109512SA patent/SG11202109512SA/en unknown
- 2020-03-02 CN CN202411228005.XA patent/CN119097618A/zh active Pending
- 2020-03-02 MA MA55199A patent/MA55199B1/fr unknown
- 2020-03-02 US US17/435,784 patent/US20220142959A1/en active Pending
- 2020-03-02 EP EP24188941.9A patent/EP4464378A3/en active Pending
- 2020-03-02 JP JP2021551939A patent/JP7555346B2/ja active Active
- 2020-03-02 KR KR1020217031422A patent/KR102941068B1/ko active Active
- 2020-03-02 KR KR1020257040124A patent/KR20250171484A/ko active Pending
- 2020-03-02 IL IL285870A patent/IL285870B2/en unknown
- 2020-03-02 HU HUE20712029A patent/HUE068527T2/hu unknown
- 2020-03-02 CN CN202080029158.5A patent/CN114040757B/zh active Active
- 2020-03-02 DK DK20712029.6T patent/DK3934637T3/da active
- 2020-03-02 LT LTEPPCT/IB2020/051767T patent/LT3934637T/lt unknown
- 2020-03-02 HR HRP20241150TT patent/HRP20241150T1/hr unknown
- 2020-03-02 EP EP20712029.6A patent/EP3934637B1/en active Active
-
2021
- 2021-09-02 MX MX2024015063A patent/MX2024015063A/es unknown
-
2024
- 2024-09-10 JP JP2024155453A patent/JP2024170602A/ja active Pending
-
2025
- 2025-06-30 AU AU2025204995A patent/AU2025204995A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022522819A5 (https=) | ||
| JP2022058688A5 (https=) | ||
| HRP20241150T1 (hr) | (n-)acetil-l-leucin za uporabu u liječenju traumatske ozljede mozga | |
| JP2013518107A5 (https=) | ||
| JP2018193377A5 (https=) | ||
| JP2015512406A5 (https=) | ||
| JP2019524834A5 (https=) | ||
| JP2014530874A5 (https=) | ||
| HRP20240168T1 (hr) | Kombinacije dolutegravira i lamivudina za liječenje hiv infekcije | |
| JP2006505587A5 (https=) | ||
| JP2005537268A5 (https=) | ||
| JP2020530857A5 (https=) | ||
| JP2014516942A5 (https=) | ||
| JP2013541583A5 (https=) | ||
| JP2015528501A5 (https=) | ||
| JP2021073257A5 (https=) | ||
| JP2015537009A5 (https=) | ||
| JP2014508758A5 (https=) | ||
| JP2016147914A (ja) | 上気道の疾患およびインフルエンザ症候群を治療するための組成物 | |
| JP2010500284A5 (https=) | ||
| JP2022532038A5 (https=) | ||
| JP2021510715A5 (https=) | ||
| JP2023531930A5 (https=) | ||
| JP2024539623A5 (https=) | ||
| JP2008508354A5 (https=) |